GCS-12-6 is a potent Th2-selective NKT cell agonist that targets the CD1d protein. It holds potential for research in autoimmune diseases, such as inflammatory bowel disease and multiple sclerosis.
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted